HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Souery Selected Research

Treatment-Resistant Depressive Disorder

10/2021Drug repositioning for treatment-resistant depression: Hypotheses from a pharmacogenomic study.
1/2021Practical recommendations for the management of treatment-resistant depression with esketamine nasal spray therapy: Basic science, evidence-based knowledge and expert guidance.
1/2019The Genetics of Treatment-Resistant Depression: A Critical Review and Future Perspectives.
1/2019Attrition in treatment-resistant depression: predictors and clinical impact.
1/2019Genome-wide association study of treatment-resistance in depression and meta-analysis of three independent samples.
2/2017A New Prediction Model for Evaluating Treatment-Resistant Depression.
1/2016The impact of serotonin receptor 1A and 2A gene polymorphisms and interactions on suicide attempt and suicide risk in depressed patients with insufficient response to treatment--a European multicentre study.
1/2016Socio-demographic and clinical predictors of treatment resistant depression: A prospective European multicenter study.
10/2015What to expect from a third step in treatment resistant depression: A prospective open study on escitalopram.
5/2013Treatment resistance in severe unipolar depression: no association with psychotic or melancholic features.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Souery Research Topics

Disease

39Major Depressive Disorder (Major Depressive Disorders)
11/2022 - 09/2007
14Treatment-Resistant Depressive Disorder
10/2021 - 07/2007
13Mood Disorders (Mood Disorder)
01/2022 - 03/2002
9Bipolar Disorder (Manic Depressive Psychosis)
01/2022 - 06/2003
8Depressive Disorder (Melancholia)
01/2021 - 07/2007
6Mental Disorders (Mental Disorder)
07/2021 - 07/2003
5Panic Disorder (Panic Attack)
12/2020 - 07/2007
4Genetic Risk Score
01/2022 - 01/2017
4Social Phobia
12/2020 - 07/2007
4Anxiety Disorders (Anxiety Disorder)
01/2017 - 07/2003
3Schizophrenia (Dementia Praecox)
04/2022 - 01/2017
3Inflammation (Inflammations)
10/2021 - 12/2014
3Agoraphobia
12/2020 - 01/2017
3Drug-Related Side Effects and Adverse Reactions
01/2015 - 09/2009
3Weight Gain
07/2011 - 09/2009
2Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder)
11/2022 - 01/2017
2Hypertension (High Blood Pressure)
01/2022 - 01/2019
2Personality Disorders (Personality Disorder)
01/2019 - 07/2007
2Sleep Initiation and Maintenance Disorders (Insomnia)
07/2011 - 09/2009
2Body Weight (Weight, Body)
04/2011 - 11/2009
1Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive)
12/2020
1Anhedonia
01/2018
1Hypothyroidism
01/2018
1Bulimia Nervosa
01/2017
1Phobic Disorders (Phobia)
01/2017
1Disease Susceptibility (Diathesis)
11/2016
1Postpartum Depression (Post-Natal Depression)
11/2016
1Dizziness (Lightheadedness)
07/2015
1Weight Loss (Weight Reduction)
04/2011
1Obesity
11/2009
1Overweight
11/2009
1Constipation
09/2009
1Neurobehavioral Manifestations
03/2009
1Mania (Manias)
11/2007
1Darier Disease (Darier's Disease)
12/2003
1Disease Progression
06/2003

Drug/Important Bio-Agent (IBA)

43Antidepressive Agents (Antidepressants)IBA
11/2022 - 07/2007
14EscitalopramFDA Link
01/2019 - 03/2009
11Nortriptyline (Aventyl)FDA LinkGeneric
01/2019 - 03/2009
9Antipsychotic Agents (Antipsychotics)IBA
11/2022 - 05/2012
6Brain-Derived Neurotrophic Factor (BDNF)IBA
01/2019 - 08/2004
4Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA
06/2022 - 08/2011
4BenzodiazepinesIBA
12/2020 - 01/2017
3Pregabalin (Lyrica)FDA Link
01/2022 - 01/2017
3Biomarkers (Surrogate Marker)IBA
07/2021 - 12/2014
3Biological ProductsIBA
01/2021 - 06/2003
3Venlafaxine Hydrochloride (Effexor)FDA LinkGeneric
01/2019 - 01/2016
3Norepinephrine (Noradrenaline)FDA LinkGeneric
12/2014 - 07/2003
2Pharmaceutical PreparationsIBA
10/2021 - 07/2011
2Tricyclic Antidepressive Agents (Tricyclic Antidepressants)IBA
01/2019 - 04/2011
2C-Reactive ProteinIBA
05/2017 - 12/2014
2Carrier Proteins (Binding Protein)IBA
05/2015 - 07/2013
2Serotonin Plasma Membrane Transport Proteins (Serotonin Transporter)IBA
09/2013 - 05/2004
2Phospholipases A2 (Phospholipase A2)IBA
08/2006 - 12/2003
1Aripiprazole (Abilify)FDA Link
11/2022
1Quetiapine Fumarate (Seroquel)FDA Link
11/2022
1Psychotropic Drugs (Psychoactive Drugs)IBA
01/2022
1Glycogen Synthase Kinase 3 betaIBA
10/2021
1rho-Associated KinasesIBA
10/2021
1fasudil (AT 877)IBA
10/2021
1EsketamineIBA
01/2021
1Nasal SpraysIBA
01/2021
1ChromatinIBA
01/2019
13,4-methylenedioxyethamphetamine (MDEA)IBA
01/2019
1CMP- N- acetylneuraminate- poly- alpha- 2,8- sialosyl sialyltransferaseIBA
01/2019
1LithiumIBA
12/2018
1Tuberculin (PPD)IBA
11/2016
1Transcription Factors (Transcription Factor)IBA
05/2015
1Adenosine Monophosphate (AMP)IBA
05/2015
1Cytochrome P-450 CYP2C19IBA
08/2013
1Cytochrome P-450 Enzyme System (Cytochrome P450)IBA
08/2013
1Cytochrome P-450 CYP1A2 (CYP1A2)IBA
08/2013
1Cytochrome P-450 CYP2D6 (CYP2D6)IBA
08/2013
1Cytochrome P-450 CYP2C9IBA
08/2013
1Mitogen-Activated Protein Kinase 1 (p42 MAP Kinase)IBA
07/2013
1ElementsIBA
07/2013
1Cyclic AMP (AMP, Cyclic)IBA
07/2013
1Calcium Channels (Calcium Channel)IBA
06/2012
1Serotonin (5 Hydroxytryptamine)IBA
01/2012
1Desipramine (Pertofrane)FDA LinkGeneric
08/2011
1CitalopramFDA LinkGeneric
08/2011
1DysbindinIBA
12/2010
1Catechol O-Methyltransferase (Methyltransferase, Catechol)IBA
07/2010
1Methylphenidate (Ritalin)FDA LinkGeneric
11/2007
1corticotropin releasing factor-binding proteinIBA
09/2007
1Substance PIBA
12/2005
15-HT2A Serotonin Receptor (5 HT2A Receptor)IBA
10/2003
1Neurotransmitter Agents (Neurotransmitter)IBA
07/2003
1Dopamine D2 Receptors (Dopamine D2 Receptor)IBA
03/2002
1Corticotropin-Releasing HormoneIBA
03/2002

Therapy/Procedure

5Therapeutics
01/2021 - 07/2003
1Wearable Electronic Devices
07/2021
1Precision Medicine
01/2019
1Drug Therapy (Chemotherapy)
12/2018
1Secondary Prevention
11/2007